top of page
vaxa_logo_FF0000_transparent.png
LET'S TALK
vaxa_logo_FF0000_transparent.png
LET'S TALK
client cases 11 this.png

CLIENT CASE STUDIES

Selected Client Assignments

Providing insights to — the challenges, the reframing, and the outcomes, across growth strategy, revenue channels, and market intelligence engagements.

Digital Health · Medical Wearables

Regulatory Navigation & Market Entry

Global academic entry achieved. Mainstream trials entered.

Academic medical center entry built the evidence base. FDA acceptance for mainstream trials followed.

Growth Strategy · Adjacent Markets

READ

Technology · Life Sciences

Building a Corporate Venture Capital Program

$25M invested across four venture funds

25 venture funds prioritized across three regions. IBM invested in four, then backed startups directly.

Growth Strategy · Venturing & Innovation

READ

Medical Devices · Consumer Health

Creating the AED Category

Category created — automatic external defibrillators

Cross-industry insight panels created a category that didn't exist. AEDs are now standard equipment everywhere.

Growth Strategy · Strategic Innovation

READ

Technology · Disaster Preparedness

Technology & Disaster Preparedness

New category of technology engagement identified

Megatrends research surfaced a structural gap in disaster response technology — before COVID exposed it globally.

Growth Strategy · Emerging Markets

READ

Medical Devices · Europe

Market Expansion & Platform Transition

Radiotherapy division acquired. Platform transition underway.

Adjacent market entry strategy delivered. Major radiotherapy acquisition completed, followed by a series of M&A transactions.

Revenue Channels · Growth Strategy

READ

Technology · Life Sciences

Life Sciences Market Entry

$100M committed within six months

$1.4B in new revenue. $125M invested. A corporate venture capability built from scratch, invested in VC in US, Europe and AP.

Growth Strategy · New Market Entry

READ

Semiconductors · Technology

IP Monetization — Digital Displays

Two new markets identified and ecosystem seeded.

Thought leader panels identified two markets for idle silicon IP. Ecosystem seeded for both--partnered with leading display manufacturer.

Growth Strategy · Monetizing IP

READ

Asia Electronics - Corporate Venture Capital

Rolling Out Corporate Venture Capital Structure

Eight investments in four years

An adhoc CVC effort became a formal unit, relocated from Japn to the US. Eight investments in four years.

Growth Strategy · Corporate Innovation

READ

Technology · Enterprise Software

Enterprise Software Channel Strategy

Complete channel strategy and partner ecosystem delivered

Channel architecture designed from the revenue target down. Ecosystem built to the specification.

Market Intelligence · New Channels

READ

Telecommunications · Europe

Strategic Reframing — Future of Communications

$1M strategic engagement. Question reframed. New strategic direction.

The question on the table was wrong. Reframing it opened a significantly larger strategic inquiry.

Growth Strategy · Venturing & Innovation

READ

Consumer Goods · Innovation

Innovation Process & IP Monetization

New innovation process operational. IP monetized across four industries.

Innovation process rebuilt for commercial outcomes. Dormant IP monetized across four new industries.

Growth Strategy · Strategic Innovation

READ

Advanced Materials · Smart Glass

Advanced Materials — Smart Glass

First customer secured before end of the assignment

Application frontier mapped across industries. Smart glass reframed as adaptive surface technology.

Growth Strategy · Future Foresight

READ

THE CONSTANT

The industry and client change on each assignment. The discipline never does.

01

These are a small set of client assignments. The pattern repeats across hundreds of engagements, in nearly every industry that has brought Vaxa a problem it was challenged with.

02

Finding the opportunity is the easy half.
Vaxa is fixated on the other half — building it until it holds up on both the income statement and a balance sheet.

03

An insight that stays on a slide is worthless. Every case on this page ends in a number — not a recommendation left on a shelf. We are singlemindedly focused on getting to lasting and tangible results.

Want a grounded but different perspective on a vexing issue?

LET'S TALK
bottom of page